|
|
|
|
| | | | USD | EUR | GBP | JPY | 83.30 | 89.11 | 103.69 | 0.54 |
| | | | AED | AUD | CHF | CAD | 17.54 | 49.53 | 64.49 | 50.06 |
| | | | HKD | SAR | SGD | ZAR | 8.28 | 17.22 | 47.46 | 4.57 |
|
|
|
|
|
|
|
|
|
|
|
Industry :
|
Hospital & Healthcare Services
|
|
|
|
|
|
|
|
|
|
52-Week-High (Rs.)
|
6871.30
|
|
|
52-Week-Low (Rs.)
|
4410.05
|
|
|
|
|
* BSE PRICES
|
|
|
|
|
Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Operational & Financial Ratios | | | | | | Earnings Per Share (Rs) | 75.44 | 39.81 | -1.84 | 33.78 | 21.75 | CEPS(Rs) | 100.94 | 65.08 | 27.46 | 68.43 | 43.30 | DPS(Rs) | 15.00 | 11.75 | 3.00 | 6.00 | 6.00 | Book NAV/Share(Rs) | 481.56 | 424.94 | 361.72 | 286.52 | 278.99 | Tax Rate(%) | 11.63 | 32.83 | 34.65 | 31.09 | 34.53 | Margin Ratios | | | | | | Core EBITDA Margin(%) | 25.77 | 23.28 | 15.23 | 14.38 | 12.19 | EBIT Margin(%) | 22.47 | 17.98 | 6.44 | 11.31 | 8.76 | Pre Tax Margin(%) | 18.81 | 13.98 | -0.87 | 6.97 | 5.55 | PAT Margin (%) | 16.63 | 9.39 | -0.57 | 4.80 | 3.63 | Cash Profit Margin (%) | 22.25 | 15.35 | 8.49 | 9.72 | 7.23 | Performance Ratios | | | | | | ROA(%) | 9.08 | 5.12 | -0.24 | 4.61 | 3.39 | ROE(%) | 16.64 | 10.12 | -0.57 | 11.95 | 7.99 | ROCE(%) | 17.43 | 14.04 | 4.10 | 15.53 | 10.58 | Asset Turnover(x) | 0.55 | 0.55 | 0.43 | 0.96 | 0.93 | Sales/Fixed Asset(x) | 0.87 | 0.85 | 0.61 | 1.47 | 1.69 | Working Capital/Sales(x) | 3.42 | 2.69 | 3.07 | 26.33 | 22.53 | Efficiency Ratios | | | | | | Fixed Capital/Sales(x) | 1.15 | 1.18 | 1.63 | 0.68 | 0.59 | Receivable days | 45.99 | 60.70 | 85.10 | 34.94 | 36.32 | Inventory Days | 6.86 | 10.69 | 35.99 | 23.64 | 24.08 | Payable days | 126.12 | 142.16 | 235.40 | 44.51 | 42.18 | Valuation Parameters | | | | | | PER(x) | 57.12 | 113.44 | 0.00 | 33.69 | 56.13 | PCE(x) | 42.69 | 69.39 | 105.71 | 16.63 | 28.20 | Price/Book(x) | 8.95 | 10.63 | 8.03 | 3.97 | 4.38 | Yield(%) | 0.35 | 0.26 | 0.10 | 0.53 | 0.49 | EV/Net Sales(x) | 9.72 | 10.89 | 9.37 | 1.90 | 2.39 | EV/Core EBITDA(x) | 34.59 | 45.29 | 59.75 | 13.08 | 19.37 | EV/EBIT(x) | 43.25 | 60.58 | 145.58 | 16.83 | 27.32 | EV/CE(x) | 5.16 | 5.72 | 4.06 | 1.68 | 2.15 | M Cap / Sales | 9.50 | 10.65 | 8.97 | 1.62 | 2.04 | Growth Ratio | | | | | | Net Sales Growth(%) | 6.99 | 31.04 | -52.48 | 17.49 | 16.06 | Core EBITDA Growth(%) | 25.00 | 100.88 | -48.81 | 38.40 | 22.33 | EBIT Growth(%) | 33.75 | 265.92 | -72.97 | 51.70 | 28.09 | PAT Growth(%) | 89.48 | 2,268.56 | -105.61 | 55.28 | 29.85 | EPS Growth(%) | 89.48 | 2,268.54 | -105.44 | 55.28 | 29.78 | Financial Stability Ratios | | | | | | Total Debt/Equity(x) | 0.25 | 0.33 | 0.44 | 0.79 | 0.83 | Current Ratio(x) | 2.53 | 2.91 | 2.00 | 1.19 | 1.23 | Quick Ratio(x) | 2.46 | 2.78 | 1.86 | 0.83 | 0.88 | Interest Cover(x) | 6.14 | 4.49 | 0.88 | 2.60 | 2.73 | Total Debt/Mcap(x) | 0.03 | 0.03 | 0.05 | 0.20 | 0.19 |
|
|
|
|
|
|